Objective response rate as a surrogate end point: A commentary

被引：19

作者：

Fleming, TR ^{[1
]}

机构：

[1] Univ Washington, Seattle, WA 98195 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 22期

关键词：

D O I：

10.1200/JCO.2005.92.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4845 / 4846

页数：2

共 8 条

[1] Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients [J].

Bruzzi, P ;

Del Mastro, L ;

Sormani, MP ;

Bastholt, L ;

Danova, M ;

Focan, C ;

Fountzilas, G ;

Paul, J ;

Rosso, R ;

Venturini, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5117-5125

[2] Perspective: Validating surrogate markers - Are we being naive? [J].

DeGruttola, V ;

Fleming, T ;

Lin, DY ;

Coombs, R .

JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) :237-246

[3] Surrogate endpoints and FDA's accelerated approval process [J].

Fleming, TR .

HEALTH AFFAIRS, 2005, 24 (01) :67-78

[4] STATISTICAL VALIDATION OF INTERMEDIATE END-POINTS FOR CHRONIC DISEASES [J].

FREEDMAN, LS ;

GRAUBARD, BI ;

SCHATZKIN, A .

STATISTICS IN MEDICINE, 1992, 11 (02) :167-178

[5]

Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.0.CO

[6]

2-1

[7]

SARGENT D, 2003, M TRANSCR US FOOD DR

[8] A NON-PARAMETRIC GRAPHICAL REPRESENTATION OF THE RELATIONSHIP BETWEEN SURVIVAL AND THE OCCURRENCE OF AN EVENT - APPLICATION TO RESPONDER VERSUS NON-RESPONDER BIAS [J].

SIMON, R ;

MAKUCH, RW .

STATISTICS IN MEDICINE, 1984, 3 (01) :35-44

← 1 →